# Xtant Medical acquires Coflex product line from Surgalign for $17M

Xtant Medical Holdings acquired the Coflex and Cofix product lines from Surgalign Holdings for $17 million, adding interlaminar stabilization devices for spinal stenosis.

- Type: Acquisition
- Announced: 2023-02-28
- Where: United States
- Value: $17.0M
- Status: completed
- Products: Coflex interlaminar stabilization device, Cofix supplemental fixation device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Xtant Medical Holdings](https://endata.com/companies/68885.md) (acquirer)
- [Surgalign Holdings](https://endata.com/companies/68886.md) (target)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2023/03/01/2618331/0/en/viewpoint-molecular-targeting-and-isoray-complete-merger-to-form-perspective-therapeutics.html), 2023-03-01: "We are thrilled to acquire the Coflex and Cofix product lines, which will help accelerate our top-line growth and position Xtant to achieve critical mass."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.